The 8th European workshop on celldeath
June 3rd Monday
June 4th Tuesday
June 5th Wednesday
June 6th Thursday
June 7th Friday
June 8th
Arrival and registration
8.45 – 10.15 Bcl-2 family
Chairs: P. Ekert
08.45 – 09.00 Introduction by Paul Ekert
09.00 – 09.15 Paul Ekert: Novel Mechanisms Regulating Bcl-2 protein family expression
09.15 – 09.30 Thomas Kaufmann: Towards understanding the functions of the Bcl-2 family member Bok
09.30 – 09.45 Ana Garcia Saez: Differences in the mechanism of membrane permeabilization by Bax and Bcl-xL relate to their function in apoptosis
09.45 – 10.00 Frank Edlich: Pro-survival Bcl-2 proteins retrotranslocate mitochondrial Bax into the cytosol
10.00 – 10.15 Fabien Llambi Bcl-2 protein dynamics in the regulation of life and death
10.15 – 10.45 Coffee break
10.45 – 12.30 Death receptor signaling
Chairs: Marion MacFarlane, Martin Leverkus
10.45 – 11.00 Introduction by Marion MacFarlane
11.00 – 11.15 Marion MacFarlane: A new DISC Model reveals a crucial role for Caspase-8 chain assembly in mediating Apoptotic Cell Death
11.15 – 11.30 Michele Hughes: A reconstituted TRAIL DISC model reveals new insights into c-FLIP regulation of procaspase-8
11.30 – 12.15 Christophe Le Clorennec: The Role of the new c-FLIP binding proteins Ku70 and Rack1 in Death Receptor mediated apoptosis: Rack1 and the DUB Ku70 : Novels regulators of c-FLIP function
12.15 – 12.30 Selcen Öztürk: Regulation of NF-κB activation by c-FLIP proteins and c- FLIP novel binding partners
12.30 – 12.45 Diana Panayotova Dimitrova: Epidermal cFLIP is a critical regulator of skin homeostasis and protects embryonic development in mice
13.00 – 14.30 Lunch
15.00 – 16.30 Pattern-recognition receptors and IAPs
Chairs: Pascal Meier, John Silke
15.00 – 15.15 Introduction by John Silke
15.15 – 15.30 John Silke: IAPs, RIPK2 and regulation of NOD signalling
15.30 – 15.45 Joseph Evans: The RIPK1/TRAF2 interaction and its role in limiting induction of the non-canonical NF-kB pathway
15.45 – 16.00 Martin Leverkus: The Ripoptosome – a molecular complex differentially regulated by cFLIP isoforms: the importance of the intracellular balance of cIAPs and RIP1
16.00 – 16.15 Conor Kearney: Regulation of TNF-induced cytokine production by IAPs
16.15 – 16.30 Stephen Tait: Mitochondria are dispensable for RIP3K mediated necroptosis
16.30 – 16.45 Najoua Lalaoui : RIP1 Kinase Activity is required for Cancer Cell Death Induced by SMAC Mimetics
16.45 – 17.15 Coffee break
17.15 – 19.15 XIAP and some TNF signalling Chairs: Pascal Meier, Mads Gyrd-Hansen
17.15 – 17.30 Pascal Meier: Caspase -9, APAF and IAPs and innate immunity
17.30 – 17.45 Mads Gyrd-Hansen: XIAP ubiquitylates RIPK2 and recruits LUBAC to regulate innate immune signaling
17.45 – 18.00 Donia Moujalled: RIPK3 sensitizes cells to killing by TNF without recruitment to complex 1, in the absence of caspase 8 and RIPK1
18.00 – 18.15 Monica Yabal: Consequences for Innate Immune responses upon loss of XIAP
18.15 – 18.30 Philip J. Jost: Inhibition of IAP proteins blocks pattern-recognition receptor-mediated fatal hepatitis in mice
18.30 – 18.45 Rune B. Damgaard: Disease-associated mutations in XIAP cause defective innate immune signalling
19.15 – 20.30 Dinner
20.30 – 22.00 Poster session I
9.00 – 11.00 Inflammation
Chairs: Seamus Martin, Henning Walczak
09.00 – 09.15 Introduction by Seamus J. Martin
09.15 – 09.30 Seamus J. Martin: Interactions between dying cells and the immune system
09.30 – 09.45 W. Wei-Lynn Wong: Inflammation before Death: Cytokine regulation by IAPs and RIPKs
09.45 – 10.00 Tom Vanden Berghe: Systematic analysis of inflammatory and cell death components in LPS-induced shock reveals correlation between survival and intestinal goblet cell hyperplasia
10.00 – 10.15 James Rickard: Necroptosis and macrophages in Sharpin dermatitis – a deadly liaison?
10.15 – 10.30 Brian Ferguson: Innate immune DNA sensing by DNA-PK
10.30 – 10.45 Anastasis Stephanou: Blocking IL-17 signalling reduces apoptosis following myocardial ischaemia/reperfusion injury
10.45 – 11.00 Ursina Gurzeler: Regulation Of FasL- And TNFα-Induced Cell Death In Murine Neutrophils
11.00 – 11.30 Coffee break
11.30 – 12.30 Autophagy
Chairs: Katja Simon, Monika Mortensen
11.30 – 11.45 Introduction by Katja Simon
11.45 – 12.00 Yang Liu: A Novel Form of Cell Death Triggered by an Autophagy-Inducing Beclin 1 Peptide
12.00 – 12.15 Monika Mortensen: The role of autophagy in human healthy hematopoietic and acute myeloid leukemia cells
12.15 – 12.30 Alec Watson: A role for autophagy in hematopoetic stem cell homeostasis and fate
13.00 – 14.30 Lunch
15.00 – 16.15 Autophagy
Chairs: Katja Simon, Monika Mortensen
15.00 – 15.15 Kanchan Phadwal: Is macroautophagy a safeguard mechanism against immunosenescence?
15.15 – 15.30 Federica Albiero: Crosstalk between autophagy and the ubiquitin proteasome system: Role of AMBRA1-DDB1 interaction.
15.30 – 15.45 Jennifer Martinez: LC3-associated phagocytosis mediates IFN-α secretion in response to DNA-immune complexes
15.45 – 16.00 Sara Galavotti: Role of the autophagy-associated factors DRAM1 and p62 in glioblastoma stem cells
16.00 – 16.15 Pierre-Emmanuel Joubert: Chikungunya virus-induced autophagy delays apoptosis via the induction of ER stress and generation of reactive oxygen species.
16.15 – 16.45 Coffee break
16.45 – 18.30 Cell death and metabolism
Chairs: Cristina Muñoz-Pinedo, Mads Daugaard
16.45 – 17.00 Introduction by Ameeta Kelekar
17.00 – 17.15 Amanda J. Stranks: Autophagy deficiency in myeloid cells leads to metabolic changes
17.15 – 17.30 Cristina Muñoz-Pinedo: Mechanisms of cell death induced by inhibition of glucose metabolism
17.30 – 17.45 Gabriel Leprivier: The eEF2 kinase is a conserved mediator of tumor adaptation to metabolic stress
17.45 – 18.00 Mads Daugaard: Control of ROS generation as a bona fide tumor suppressor mechanism
18.15 – 18-30 Lisette Potze: Novel mechanistic aspects of Betulinic acid-induced cell death
19.00 – 20.30 Dinner
20.30 – 22.00 Poster session II + Bar talk (Wayne Patton, Enzo Life Sciences)
9.00 – 11.00 New mechanistic insights in tumorigenesis (I)
Chairs: Ulrich Maurer, Michael Hahne
09.00 – 09.15 Valeria Lascano: APRIL enhances tumor formation in mouse models of colorectal cancer and correlates with poor survival of patients
09.15 – 09.30 Martijn H.A. van Attekum: TNF-family members BAFF and APRIL confer survival and drug resistance in Chronic Lymphocytic Leukemia in novel models of the lymph node microenvironment
09.30 – 09.45 Ulrich Maurer: The role of MCL-1 phosphorylation for lymphocyte development and Myc-induced lymphomagenesis
09.45 – 10.00 Sabine Spinner: The role of the anti-apoptotic Bcl-2 proteins Bcl-xL and Mcl-1 in survival of thymic T-cell derived Non-Hodgkin lymphoma
10.00 – 10.15 Inga Melzer: The antiapoptotic protein Aven is involved in murine mammary gland development and breast cancer initiation/maintenance
10.15 – 10.30 Carmen Palacios: Control of FLIPL expression and TRAIL resistance by the extracellular signal-regulated kinase (ERK)1/2 pathway in breast epithelial cells
10.30 – 11.00 Coffee break
11.00 – 12.15 New mechanistic insights in tumorigenesis (II)
Chairs: Jan Paul Medema, Huseyin Mehmet
11.00 – 11.15 Lukas Peintner: Investigating the role of RAIDD in Caspase-2-dependent tumor suppression
11.15 – 11.30 Sara Pensa: The PI3K regulatory subunits p50alpha and p55alpha regulate cell death in vivo
11.30 – 11.45 Mikkel Rohde: The role of heat shock protein 70-2 in alternative splicing in cancer cells
11.45 – 12.00 Bettina Schwamb: FAM96A is a regulator of the intrinsic apoptosis pathway and involved in tumorigenesis of gastrointestinal stromal tumors
12.00 – 12.15 Sonja Aits: Identification of cytoskeleton-associated proteins essential for cancer cell survival and lysosomal stability
12.30 – 13.30 Lunch
Free afternoon
Rafting: 1st group 13.30 – 15.00, 2nd group 15.00 – 16.30, 3rd group 16.30 – 18.00 (pick-up from hotel)
Mountain biking: Start 16.00 – Return 19.00 (pick-up from hotel)
Hiking: Start 14.30 from parking Les Bains (close to Seminar room la salle du dôme), return 17.30 at the latest
19.30 Bus pick-up from hotel to go to Puy St. Vincent, followed by 10 min walk to Chalet le Pralong
20.00 – 22.00 Special dinner with view on the old town of Briançon
09.00 – 10.15 New mechanistic insights in tumorigenesis (III)
Chairs: Vincenzo de Laurenzi, Giorgio Stassi
09.00 – 09.15 Alice Turdo: Role of Sam68 in modulating the tumorigenic and metastatic potential of breast Cancer Stem Cells
09.15 – 09.30 Simone Di Franco: p63 role in breast cancer progression
09.30 – 09.45 Annika Baude: LEDGF promotes DNA end resection and efficient DNA repair by homologous recombination
09.45 – 10.00 Antonella Di Cola: Nucleophosmin nucleolar localization depends on G-quadruplex binding at rDNA: implications for NPM1-associated acute myeloid leukemia
10.00 – 10.15 Tania Aaes-Jørgensen: Knockdown of HDGFRP2 impairs homologous recombination and CtIP recruitment to DNA double strand breaks
10.15 – 10.45 Coffee break
10.45 – 12.30 Tumor therapy I
Chairs: Michael Bots, Ricky Johnstone
10.45 – 11.00 Introduction by Ricky Johnstone
11.00 – 11.15 Ricky Johnstone: Identifying histone deacetylases important for tumor development, growth and survival through sophisticated gene knockdown techniques
11.15 – 11.30 Katrina J Falkenberg: A Genome-wide screen for novel genes involved in sensitisation to Histone Deacetylase Inhibitors
11.30 – 11.45 Selcuk Colak: Inhibition of HDACs sensitizes chemotherapeutic resistant colon Cancer Stem Cells
11.45 – 12.00 Michaela Waibel: Therapeutic activity of HDACi in a model of NOTCH1-driven T-ALL
12.00 – 12.15 Dagmar Kumls: Three dimensional melanoma treatment
12.15 – 12.30 Markus Rehm: Case-specific prediction of cell death responsiveness in malignant melanoma
13.00 – 14.30 Lunch
15.00 – 16.30 Tumor therapy II
Chairs: Michael Bots, Eric Eldering
15.00 – 15.15 Michael Bots: Targeting cancer stem cells as therapeutics in a mouse model of colon cancer
15.15 – 15-30 Anne Marie Ellegaard: Sunitinib and SU11652 induce permeabilization of the lysosomal membrane and revert multidrug resistance
15.30 – 15.45 Ana Carolina Martinez-Torres: CD47-mediated caspase-independent cell death: a new therapeutic tool to overcome apoptotic avoidance in chronic lymphocytic leukemia
15.45 – 16.00 Inge Verbrugge: Eradication of established mammary tumors using novel combinations of radiotherapy and immunomodulatory antibodies
16.00 – 16.15 Eric Eldering: Mapping the targets of Dasatinib in chronic lymphocytic leukemia; distinct roles for Abl and Btk in drug resistance and adhesion/migration
16.30 – 17.00 Coffee break
17.00 – 20.00 Sports (pétanque)
20.00 – 21.30 Dinner
21.30 – … Party
8.00 – 10.00 Breakfast
Departure